发明名称 USE OF XANTHOPHYLLS, ASTAXANTHIN E.G., FOR TREATMENT OF AUTOIMMUNE DISEASES, CHRONIC VIRAL AND INTRACELLULAR BACTERIAL INFECTIONS
摘要 The use of at least one type of xanthophylls for the production of a medicament for suppression of excessive Th1 cell mediated immune responses a nd stimulation of Th2 cell mediated immune responses in a patient during ongoin g infection and/or inflammation in said patient is disclosed. Excessive Th1 ce ll mediated immune responses are caused by such autoimmune diseases and chronic viral and intracellular bacterial infections as Psoriasis vulgaris, Multiple sclerosis (MS), Rheumatoid arthritis, Crohn's disease, Insulin-dependent diabetes mellitus, Tuberculosis (TB), Acute graft-versus-host disease (transplant rejection) and HIV virus infection. The preferred type of xanthophyll is astaxanthin, particularly in a form esterified with fatty acids, obtainable by for example culturing the algae Haematococcus sp. Further, a method of suppressing excessive Th1 mediated immune responses and stimulating Th2 cell mediated immune responses in a patient during ongoing infection and/or inflammation in said patient is disclosed.
申请公布号 CA2388785(A1) 申请公布日期 2001.04.12
申请号 CA20002388785 申请日期 2000.10.05
申请人 ASTACAROTENE AB 发明人 BOTTIGER, PER;LIGNELL, AKE
分类号 A61P3/10;A61K31/047;A61K31/122;A61K31/215;A61K31/23;A61P17/06;A61P19/02;A61P25/00;A61P29/00;A61P31/04;A61P31/12;A61P31/18;A61P37/00;A61P37/06;(IPC1-7):A61K31/122 主分类号 A61P3/10
代理机构 代理人
主权项
地址